Table 3 Outcomes
Patient outcomes (n = 158) | |
|---|---|
30-day mortality | 9 (5.6%) |
Percentage of 30-day mortalities undergoing urgent TEVAR | 5 (55.6%) |
Respiratory failure | 2 (1.3%) |
Aneurysmal hemorrhage | 1 (0.6%) |
Cerebral hemorrhage | 1 (0.6%) |
Hemoptysis caused by aortobronchial fistula | 1 (0.6%) |
Unknown | 4 (2.5%) |
Postoperative stroke | 4 (2.5%) |
Spinal cord ischemia | 0 (0) |
Technical success* | 133 (91.0%) |
Results from postoperative CTA (< 90 days, n = 144) | |
Type Ia endoleak | 8 (5.6%) |
Type Ib endoleak | 4 (2.8%) |
Type II endoleak | 32 (22.2%) |
From left subclavian artery | 5 (3.5%) |
From bronchial/intercostal arteries | 27 (18.8%) |
Type III endoleak | 1 (0.7%) |
Overall Survival | |
One year | 76.4% (70.0–83.3, SE 0.034%) |
Five years | 52.9% (45.0–62.2, SE 0.043%) |
Ten years | 26.8% (18.2–39.5, SE 0.053%) |
Freedom of reintervention | |
One year | 80.0% (72.6–88.1, SE 0.039%) |
Five years | 52.8% (41.4–67.4, SE 0.065%) |
Ten years | 48.0% (35.3–65.3, SE 0.075%) |